
Sign up to save your podcasts
Or


Send us a text
NASH-TAG 2022 takes place in Deer Valley Utah and on-line from January 7-8, 2022. Join Surfing NASH to learn about important updates from the three consortia (LITMUS, NIMBLE and the NIH Cirrhosis Network), "new news" in wet biomarkers and combination therapy and a stimulating session with PathAI and Histoindex covering artificial intelligence.
Co-chair Stephen Harrison leads the panel through key sessions from NASH-TAG. This conversation starts with a review of Session 4, in which Quentin Anstee presents updates from the LITMUS consortium, Arun Sanyal presents updates from NIMBUS, and Vijay Shah provides information about the NIH Cirrhosis Network. From there, Stephen reviews Session 5 with its focus on artificial intelligence leaders PathAI and Histoindex. The conversation concludes by reviewing the eclectic and intriguing Session 6, "What's New Out There and How To Interpret What It All Means," which has talks on the AASLD NASH Task Force, news on wet biomarkers and an update on combination therapy.
By SurfingNASH.com3.9
2424 ratings
Send us a text
NASH-TAG 2022 takes place in Deer Valley Utah and on-line from January 7-8, 2022. Join Surfing NASH to learn about important updates from the three consortia (LITMUS, NIMBLE and the NIH Cirrhosis Network), "new news" in wet biomarkers and combination therapy and a stimulating session with PathAI and Histoindex covering artificial intelligence.
Co-chair Stephen Harrison leads the panel through key sessions from NASH-TAG. This conversation starts with a review of Session 4, in which Quentin Anstee presents updates from the LITMUS consortium, Arun Sanyal presents updates from NIMBUS, and Vijay Shah provides information about the NIH Cirrhosis Network. From there, Stephen reviews Session 5 with its focus on artificial intelligence leaders PathAI and Histoindex. The conversation concludes by reviewing the eclectic and intriguing Session 6, "What's New Out There and How To Interpret What It All Means," which has talks on the AASLD NASH Task Force, news on wet biomarkers and an update on combination therapy.

32,242 Listeners

30,746 Listeners

9,742 Listeners

103 Listeners

21,266 Listeners

3,372 Listeners

113,081 Listeners

56,914 Listeners

9,561 Listeners

8,524 Listeners

10,251 Listeners

6,446 Listeners

0 Listeners

421 Listeners

680 Listeners